Véronique Boyer
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Véronique Boyer.
Biology of the Cell | 2009
Sirpa Aho; Julien Lupo; Pierre-Alain Coly; Amélie Sabine; Marc Castellazzi; Patrice Morand; Alain Sergeant; Evelyne Manet; Véronique Boyer; Henri Gruffat
Background information. We characterized previously a cellular protein through its interaction with cellular and viral transcription factors from the bZip family. The corresponding mRNA was detected in a wide range of cell types and the protein was highly expressed in the nucleus of human keratinocytes. On the basis of these observations, we named this protein ubinuclein.
Journal of Virology | 2011
Henri Gruffat; Julien Lupo; Patrice Morand; Véronique Boyer; Evelyne Manet
ABSTRACT The Epstein-Barr Virus (EBV) productive cycle is initiated by the expression of the viral trans-activator EB1 (also called Zebra, Zta, or BZLF1), which belongs to the basic leucine zipper transcription factor family. We have previously identified the cellular NACos (nuclear and adherent junction complex components) protein ubinuclein (Ubn-1) as a partner for EB1, but the function of this complex has never been studied. Here, we have evaluated the consequences of this interaction on the EBV productive cycle and find that Ubn-1 overexpression represses the EBV productive cycle whereas Ubn-1 downregulation by short hairpin RNA (shRNA) increases virus production. By a chromatin immunoprecipitation (ChIP) assay, we show that Ubn-1 blocks EB1-DNA interaction. We also show that in epithelial cells, relocalization and sequestration of Ubn-1 to the tight junctions of nondividing cells allow increased activation of the productive cycle. We propose a model in which Ubn-1 is a modulator of the EBV productive cycle: in proliferating epithelial cells, Ubn-1 is nuclear and inhibits activation of the productive cycle, whereas in differentiated cells, Ubn-1 is sequestrated to tight junctions, thereby allowing EB1 to fully function in the nucleus.
Virology Journal | 2014
Charlotte Sueur; Julien Lupo; Philippe J. Mas; Patrice Morand; Véronique Boyer
BackgroundEpstein-Barr virus (EBV) is associated with 20-40% of Hodgkin’s Lymphoma (HL) cases. EBV-encoded latent membrane protein 1 (LMP1) is a well-known oncogenic protein and two C-terminal deletion variants, del30-LMP1 and del69-LMP1, have been described in animal models to be more tumorigenic than the wild-type form. This work aims to detail the implication of LMP1 in the development of HL and to characterize the particular effects of these variants.MethodsWe established HL-derived cell lines stably transfected with the pRT-LMP1 vector coding for the EBNA1 gene and allowing expression of the different LMP1 variants under the control of a doxycyclin-inducible promoter. Communication between cells was assessed by measuring the expression of various pro-inflammatory cytokines by flow cytometry after intracellular LMP1 and cytokine double staining. Proliferative properties of LMP1 variants were also compared by studying the repartition of cells in the different phases of the cell cycle after EdU incorporation combined to LMP1 and DAPI staining.ResultsAll LMP1 proteins induced the expression of several pro-inflammatory cytokines such as TNF-α, TNF-β, IL-6, RANTES/CCL5 and IFN-γ. However, the del30-LMP1 variant induced cytokine expression at a lower level than the other variants, especially IFN-γ, while the del69-LMP1 variant stimulated greater cytokine expression. In addition, we measured that all LMP1 proteins greatly impacted the cell cycle progression, triggering a reduction in the number of cells in S-phase and an accumulation of cells in the G2/M phase compared to the HL-non induced cells. Interestingly, the del30-LMP1 variant reduced the number of cells in S-phase in a significantly greater manner and also increased the number of cells in the G0/G1 phase of the cell cycle.ConclusionWeak IFN-γ expression and specific alteration of the cell cycle might be a way for del30-LMP1 infected cells to escape the immune anti-viral response and to promote the development of cancer. The differences observed between the LMP1 variants reflect their own oncogenic properties and eventually impact the development of HL.
Cellular Immunology | 1990
Véronique Boyer; Madeleine Duc Dodon; Louis Gazzolo
Viral particles obtained from HTLV-I (human T cell leukemia virus, type I)-transformed T cell lines induced immunoglobulin production by normal peripheral blood lymphocytes. Conversely, no immunoglobulin could be detected in the supernatant medium in purified B cells cultivated with HTLV-I, suggesting that the presence of T cells is mandatory for HTLV-I to induce B cell polyclonal activation. The T cell help was mediated by soluble factors, as indicated in experiments showing that cell-free conditioned medium from T lymphocytes activated by HTLV-I was able to induce B cell proliferation and differentiation. Furthermore, a direct effect of HTLV-I on B cell proliferation was demonstrated when viral particles were added to purified B cells together with suboptimal doses of Staphylococcus aureus Cowan strain I (SAC). These observations show that an immediate early effect of HTLV-I infection was exerted on B cells, mainly in a T cell-dependent manner. Such an effect may account for the hypergammaglobulinemia observed in HTLV-I seropositive individuals, and in patients with HTLV-I-associated neurological disorders.
Religião & Sociedade | 2013
Véronique Boyer
This article tells the story of a Nordestino, Braz, who went to the Amazonian state of Acre during World War II, where he became one of the first ministers of the Assembleia de Deus. Through an analysis of this narrative the article draws attention to religious discourse and practice with the social, political and economic interests of the protagonists. Although the minister explains his mission as the result of a divine calling, there can be little doubt that it is also shaped by the alliances and disputes of a more material nature.
Journal of Virology | 1997
Christine Cartier; Marcel Deckert; Christophe Grangeasse; Richard J. Trauger; Fred C. Jensen; Alain Bernard; Alain J. Cozzone; Claude Desgranges; Véronique Boyer
Journal of Immunology | 1999
Pascale Tacnet-Delorme; Véronique Boyer; Nicole M. Thielens; Jean-François Hernandez; Isabelle Bally; Robert B. Sim; Claude Desgranges; Gérard J. Arlaud
Mana-estudos De Antropologia Social | 1999
Véronique Boyer
L'Homme | 1996
Véronique Boyer
Journal of Latin American Studies | 2014
Véronique Boyer